Effect of combination immunotherapy on tumor growth, survival, and intratumoral immune infiltration in transgenic murine model of melanoma.

2018 
e21610Background: Talimogene Laherparepvec (T-Vec), a modified Herpes Simplex Type I (HSV I) virus, is the first oncolytic virus to be FDA approved for the treatment of cancer. T-Vec has two propos...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []